Literature DB >> 28648357

Acidic stress enhances CovR/S-dependent gene repression through activation of the covR/S promoter in emm1-type group A Streptococcus.

Chuan Chiang-Ni1, Huei-Chuan Tseng2, Chia-Hui Hung3, Cheng-Hsun Chiu4.   

Abstract

Streptococcus pyogenes (group A Streptococcus) is a clinically important gram-positive bacterium that causes severe diseases with high mortality. Spontaneous mutations in genes encoding the CovR/CovS two-component regulatory system have been shown to derepress expression of virulence factors and are significantly associated with invasiveness of infections. Sensor kinase CovS senses environmental signals and then regulates the levels of phosphorylated CovR. In addition, CovS is responsible for survival of group A Streptococcus under acidic stress. How this system regulates the expression of CovR-controlled genes under acidic stress is not clear. This study shows that the expression of CovR-controlled genes, including hasA, ska, and slo, is repressed under acidic conditions by a CovS-dependent mechanism. Inactivation of CovS kinase activity or CovR protein phosphorylation derepresses the transcription of these genes under acidic conditions, suggesting that the phosphorylation of CovR is required for the repression of the CovR-controlled genes. Furthermore, the promoter activity of the covR/covS operon (pcov) was upregulated after 15min of incubation under acidic conditions. Replacement of pcov with a constitutively activated promoter abrogated the acidic-stress-dependent repression of the genes, indicating that the pH-dependent pcov activity is directly involved in the repression of CovR-controlled genes. In summary, the present study shows that inactivation of CovS not only derepresses CovR-controlled genes but also abrogates the acidic-stress-dependent repression of the genes; these phenomena may significantly increase bacterial virulence during infection.
Copyright © 2017 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Acidic stress; CovR/CovS; Group A Streptococcus; NADase; SLO

Mesh:

Substances:

Year:  2017        PMID: 28648357     DOI: 10.1016/j.ijmm.2017.06.002

Source DB:  PubMed          Journal:  Int J Med Microbiol        ISSN: 1438-4221            Impact factor:   3.473


  6 in total

1.  Phosphorylation at the D53 but Not the T65 Residue of CovR Determines the Repression of rgg and speB Transcription in emm1- and emm49-Type Group A Streptococci.

Authors:  Chih-Yuan Kao; Chih-Yun Hsu; Chuan Chiang-Ni; Cheng-Hsun Chiu
Journal:  J Bacteriol       Date:  2019-01-28       Impact factor: 3.490

2.  Effect of Phosphatase Activity of the Control of Virulence Sensor (CovS) on Clindamycin-Mediated Streptolysin O Production in Group A Streptococcus.

Authors:  Chuan Chiang-Ni; Huei-Chuan Tseng; Yong-An Shi; Cheng-Hsun Chiu
Journal:  Infect Immun       Date:  2019-11-18       Impact factor: 3.441

3.  In silico characterisation of the two-component system regulators of Streptococcus pyogenes.

Authors:  Sean J Buckley; Peter Timms; Mark R Davies; David J McMillan
Journal:  PLoS One       Date:  2018-06-21       Impact factor: 3.240

4.  Cytotoxicity and Survival Fitness of Invasive covS Mutant of Group A Streptococcus in Phagocytic Cells.

Authors:  Chuan Chiang-Ni; Yong-An Shi; Chih-Ho Lai; Cheng-Hsun Chiu
Journal:  Front Microbiol       Date:  2018-10-30       Impact factor: 5.640

5.  Incidence and Effects of Acquisition of the Phage-Encoded ssa Superantigen Gene in Invasive Group A Streptococcus.

Authors:  Chuan Chiang-Ni; Yen-Shan Liu; Chieh-Yu Lin; Chih-Yun Hsu; Yong-An Shi; Yi-Ywan M Chen; Chih-Ho Lai; Cheng-Hsun Chiu
Journal:  Front Microbiol       Date:  2021-06-04       Impact factor: 5.640

6.  Phosphatase activity of the control of virulence sensor kinase CovS is critical for the pathogenesis of group A streptococcus.

Authors:  Nicola Horstmann; Chau Nguyen Tran; Chelcy Brumlow; Sruti DebRoy; Hui Yao; Graciela Nogueras Gonzalez; Nishanth Makthal; Muthiah Kumaraswami; Samuel A Shelburne
Journal:  PLoS Pathog       Date:  2018-10-31       Impact factor: 6.823

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.